A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.
Clinical trial NCT07462468 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07462468
- Sponsor
- WestVac Biopharma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-10
- Primary completion
- 2027-03-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.